Literature DB >> 2414294

Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine.

M A Lischwe, R L Ochs, R Reddy, R G Cook, L C Yeoman, E M Tan, M Reichlin, H Busch.   

Abstract

A new scleroderma antigen of Mr = 34,000; pI, 8.5 has been identified. This 34-kDa protein is a nucleolar protein as determined by immunostaining procedures with affinity-purified antibodies. The 34-kDa protein was shown to localize to the fibrillar regions of the nucleolus by immunoelectron microscopy. Antibodies against the 34-kDa protein precipitate U3 RNA-containing particles. The 34-kDa protein has been isolated from Novikoff hepatoma cell nucleoli by ion exchange and reverse-phase column chromatography. The protein contains 4.1 mol % NG,NG-dimethylarginine (DMA) and 22.8 mol % glycine. It is the most highly arginine-methylated protein thus far detected in higher eukaryotes. This nucleolar 34-kDa protein resembles several nucleoplasmic proteins that are associated with heterogeneous nuclear RNA with respect to isoelectric point, Mr, presence of NG,NG-dimethylarginine, and its high glycine content. The amino-terminal sequence of the first 31 residues of the 34-kDa protein is: Met-Lys-Pro-Gly-Phe-Ser-Pro-DMA-Gly-Gly-Gly-Phe-Gly-Gly-DMA-Gly-Gly- Phe-Gly-Asp-DMA-Gly-Gly-DMA-Gly-Gly-Gly-DMA-Gly-Gly-DMA. In the first 31 residues, there are 16 glycine, 6 DMA, and 3 phenylalanine residues. This is a novel demonstration of clusters of glycine and DMA in a protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414294

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  103 in total

1.  Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140.

Authors:  Y Yang; C Isaac; C Wang; F Dragon; V Pogacic; U T Meier
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

2.  Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals.

Authors:  M Arese; Y Chen; R Z Florkiewicz; A Gualandris; B Shen; D B Rifkin
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

3.  Enzymic methylation of arginyl residues in -gly-arg-gly- peptides.

Authors:  Y L Hyun; D B Lew; S H Park; C W Kim; W K Paik; S Kim
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

4.  Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides.

Authors:  Xing Zhang; Xiaodong Cheng
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

5.  Methods to detect antifibrillarin antibodies in patients with systemic sclerosis (SSc): a comparison.

Authors:  Josefina Huerta García; Monica Delgado Osuna; Filiberto Martinez Castrejon; Laura Guzman Enriquez; Pedro A Reyes; J Jesus Cortes Hermosillo
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

6.  Accumulation of U14 small nuclear RNA in Saccharomyces cerevisiae requires box C, box D, and a 5', 3' terminal stem.

Authors:  G M Huang; A Jarmolowski; J C Struck; M J Fournier
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

7.  Characterization of karyopherin cargoes reveals unique mechanisms of Kap121p-mediated nuclear import.

Authors:  Deena M Leslie; Wenzhu Zhang; Benjamin L Timney; Brian T Chait; Michael P Rout; Richard W Wozniak; John D Aitchison
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Differences in snRNP localization between transformed and nontransformed cells.

Authors:  D L Spector; G Lark; S Huang
Journal:  Mol Biol Cell       Date:  1992-05       Impact factor: 4.138

9.  Nuclear accumulation of basic fibroblast growth factor as a predictor for the recurrence of pituitary adenomas.

Authors:  Shinji Fukui; Naoki Otani; Hiroshi Nawashiro; Akiko Yano; Takahito Miyazawa; Akira Ohnuki; Nobusuke Tsuzuki; Hiroshi Katoh; Shoichiro Ishihara; Takamoto Suzuki; Katsuji Shima
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

10.  Antibodies against a novel nucleolar and cytoplasmic antigen (p105-p42) present in the sera of patients with a subset of rheumatoid arthritis (RA) with signs of scleroderma.

Authors:  M Labrador; A Algueró; C Díaz; C Geli; E Pérez; J García-Valero; J L Rodriguez-Sanchez; C Gelpí
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.